Simvastatin, due to its protective effects on osteoblasts by acting on the mevalonate pathway and inhibiting osteoclastogenesis by blocking the RANKL pathway, is now considered to be a potential drug for osteoporosis treatment (39). The gene discussed is TNFSF11; the disease is osteoporosis.